Medical Care Technologies Inc. Expands AI Platform to Detect Glaucoma and Cataracts
Medical Care Technologies (OTC:MDCE) has enhanced its AI Facial Health Risk Estimator platform to include detection capabilities for glaucoma and cataracts. The expanded platform now analyzes high-resolution facial and ocular images to identify corneal opacity, lens clouding, and early optic nerve changes.
The integration creates a comprehensive preventive care solution by combining eye health monitoring with existing systemic and dermatological metrics. CEO Marshall Perkins emphasized the platform's holistic approach to early detection of vision-threatening conditions.
Medical Care Technologies (OTC:MDCE) ha aggiornato la sua piattaforma AI Facial Health Risk Estimator per includere funzionalità di rilevamento del glaucoma e della cataratta. La piattaforma ampliata analizza immagini facciali e oculari ad alta risoluzione per identificare opacità corneali, opacità del cristallino e precoci cambiamenti del nervo ottico.
L'integrazione crea una soluzione completa di prevenzione combinando il monitoraggio della salute oculare con metriche sistemiche e dermatologiche esistenti. Il CEO Marshall Perkins ha sottolineato l'approccio olistico della piattaforma per un rilevamento precoce di condizioni che minacciano la vista.
Medical Care Technologies (OTC:MDCE) ha mejorado su plataforma AI Facial Health Risk Estimator para incluir capacidades de detección de glaucoma y cataratas. La plataforma ampliada ahora analiza imágenes faciales y oculares de alta resolución para identificar opacidades de la córnea, nublación del lente y cambios tempranos del nervio óptico.
La integración crea una solución integral de cuidado preventivo al combinar el monitoreo de la salud ocular con métricas sistémicas y dermatológicas existentes. El CEO Marshall Perkins enfatizó el enfoque holístico de la plataforma para la detección temprana de condiciones que amenazan la visión.
Medical Care Technologies (OTC:MDCE)가 녹내장과 백내장 탐지 기능을 포함하도록 AI Facial Health Risk Estimator 플랫폼을 향상시켰습니다. 확장된 플랫폼은 이제 고해상도 얼굴 및 눈 이미지를 분석하여 각막 혼탁, 렌즈 흐림, 초기 시신경 변화 등을 식별합니다.
이 통합은 눈 건강 모니터링을 기존의 전신 및 피부과 지표와 결합하여 포괄적인 예방 관리 솔루션을 제공합니다. CEO Marshall Perkins는 시력에 위협이 되는 질환의 조기 발견을 위한 플랫폼의 홀리스틱한 접근 방식을 강조했습니다.
Medical Care Technologies (OTC:MDCE) a amélioré sa plateforme AI Facial Health Risk Estimator pour inclure des capacités de détection de glaucome et de cataractes. La plateforme élargie analyse désormais des images faciales et oculaires haute résolution pour identifier l’opacité cornéenne, l’opacification du cristallin et les premiers changements du nerf optique.
L’intégration crée une solution de prévention globale en combinant le suivi de la santé oculaire avec les métriques systémiques et dermatologiques existantes. Le PDG Marshall Perkins a souligné l’approche holistique de la plateforme pour la détection précoce des affections menaçant la vision.
Medical Care Technologies (OTC:MDCE) hat seine AI Facial Health Risk Estimator-Plattform verbessert, um Erkennungsfunktionen für Glaukom und Katarakt zu integrieren. Die erweiterte Plattform analysiert nun hochauflösende Gesichts- und Augenbilder, um Hornhauttrübungen, Linsentrübungen und frühe Veränderungen des Sehnervs zu identifizieren.
Die Integration schafft eine umfassende präventive Lösung, indem die Augenhofer Gesundheit mit bestehenden systemischen und dermatologischen Metriken kombiniert wird. CEO Marshall Perkins betonte den ganzheitlichen Ansatz der Plattform zur frühzeitigen Erkennung visionärer Bedrohungen.
Medical Care Technologies (OTC:MDCE) قامت بتحسين منصّتها AI Facial Health Risk Estimator لتتضمن قدرات كشف الزَرَق ( glaucoma ) و الساد ( cataracts ). الآن تحلل المنصة الموسعة صوراً وجهية وعينية عالية الدقة لتحديد العُتامة القرنية وتغيّرات مبكرة في العصب البصري.
يُنشئ الاندماج حلاً شاملاً للرعاية الوقائية من خلال دمج رصد صحة العين مع المقاييس النظامية والجلدية الموجودة. وأكد الرئيس التنفيذي مارشال بيركنز على النهج الشامل للمنصة من أجل الكشف المبكر عن الحالات التي تهدد الرؤية.
Medical Care Technologies (OTC:MDCE) 已增强其 AI 面部健康风险评估平台，使其具备对青光眼和白内障的检测能力。扩展的平台现在能够分析高分辨率的面部和眼部图像，以识别角膜混浊、晶状体混浊和视神经早期变化。
该集成为眼部健康监测与现有的系统性及皮肤科指标相结合，提供一个全面的预防保健解决方案。首席执行官 Marshall Perkins 强调了该平台在及早发现威胁视力疾病方面的整体性方法。
- Integration of glaucoma and cataract detection expands product capabilities
- Platform enhancement addresses major global vision health issues
- Creation of a more comprehensive preventive care solution
- None.
MESA, ARIZONA / ACCESS Newswire / September 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced that its AI Facial Health Risk Estimator now includes early detection and monitoring of glaucoma and cataracts, two leading causes of vision loss globally.
Using high-resolution facial and ocular image analysis, the platform detects:
Corneal opacity and lens clouding for cataracts
Early optic nerve changes and other glaucoma biomarkers
This integration allows patients and clinicians to monitor eye health alongside systemic and dermatological metrics, creating a comprehensive preventive care solution.
"Our AI platform is holistic," said Marshall Perkins, CEO of MDCE. "Detecting vision-threatening conditions early preserves sight and advances global standards in preventive medicine."
Company Websites: www.medicalcaretechnologies.com | www.mdcestock.com
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK: MDCE) leverages AI for early disease detection across dermatology, neurology, ocular, and systemic health domains.
Safe Harbor Statement:
This release contains forward-looking statements; actual results may differ due to risks and uncertainties.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
What new features did Medical Care Technologies (MDCE) add to its AI platform in September 2025?
How does MDCE's AI platform detect glaucoma and cataracts?
What is the purpose of MDCE's AI Facial Health Risk Estimator?
Who is the CEO of Medical Care Technologies (MDCE)?
